Live feed17:00:00·168dPRReleasevia QuantisnowAlumis to Host Conference Call and Webcast to Report Phase 3 ONWARD Topline Data for Envudeucitinib in Moderate-to-Severe Plaque PsoriasisByQuantisnow·Wall Street's wire, on your screen.ALMS· Alumis Inc.Health Care
